Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Closure Medical

This article was originally published in The Tan Sheet

Executive Summary

Liquiderm cyanoacrylate bandages to hit shelves during first quarter of 2002, developer says July 24. Product to be marketed by J&J Consumer Products through deal with Raleigh, N.C.-based Closure (1"The Tan Sheet" June 4, p. 10). Closure revenues jump 37% to $4.4 mil. for second quarter, partly driven by sales of Orabase Soothe-N-Seal to Colgate. Net income totals $441,000, up from $488,000 loss in prior-year period, firm notes

Liquiderm cyanoacrylate bandages to hit shelves during first quarter of 2002, developer says July 24. Product to be marketed by J&J Consumer Products through deal with Raleigh, N.C.-based Closure (1 (Also see "Colgate Orabase Soothe-N-Seal Dentist Detailing, Sampling Underway" - Pink Sheet, 4 Jun, 2001.)). Closure revenues jump 37% to $4.4 mil. for second quarter, partly driven by sales of Orabase Soothe-N-Seal to Colgate. Net income totals $441,000, up from $488,000 loss in prior-year period, firm notes.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS092839

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel